tiprankstipranks
Aspira Women’s Health CFO Replaced, CEO Takes Interim Role
Company Announcements

Aspira Women’s Health CFO Replaced, CEO Takes Interim Role

Aspira Women’s Health (AWH) has shared an announcement.

Aspira Women’s Health Inc. has terminated Dr. Torsten Hombeck as CFO due to a personal civil matter that does not relate to the company’s operations or finances. CEO Nicole Sandford has stepped in as interim CFO while the company searches for a permanent replacement. Sandford’s extensive executive background, including over three decades of experience in strategy, operations, and risk management, ideally positions her to manage the company’s financial responsibilities during this transition.

Find detailed analytics on AWH stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyAspira Women’s Health announces preliminary OvaWatch, OvaSuite Q2 results
GlobeNewswireAspira Women’s Health Announces Closing of $1.9 Million Private Placement Equity Financing
GlobeNewswireAspira Women’s Health Announces $1.935 Million Private Placement Equity Financing
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!